effici
synthesi
new
seri
acyclonucleotid
analogu
linker
describ
start
diethyl
azidomethyl
select
alkyn
microwav
irradi
sever
odiethylphosphon
acyclonucleotid
transform
respect
phosphon
acid
compound
evalu
vitro
activ
broad
varieti
dna
rna
virus
cytostat
activ
murin
leukaemia
human
tlymphocyt
cem
human
cervix
carcinoma
hela
cell
acyclonucleotid
exhibit
activ
herp
simplex
virus
hel
cell
cultur
ec
mm
felin
herp
viru
ec
mm
crfk
cell
cultur
compound
preferenti
inhibit
prolifer
human
tlymphocyt
cem
cell
ic
mm
rang
fig
nucleosid
analogu
natur
nucleobas
connect
ring
methylen
linker
ie
et
al
european
journal
medicin
chemistri
conform
prefer
phosphon
describ
paper
ascertain
analys
h
h
p
c
nmr
spectra
sinc
vicin
protoneproton
coupl
within
h
ce
ch
fragment
phosphon
observ
around
hz
conclud
rotat
around
pch
ech
n
bond
fulli
unrestrict
hand
base
valu
j
hz
j
hz
small
valu
j
j
ca
hz
one
may
deduc
phosphon
exist
antiperiplanar
conform
probabl
stabilis
intramolecular
hydrogen
bond
fig
conform
behaviour
threecarbon
linker
diethoxyphosphoryl
substitut
group
phosphon
primarili
govern
presenc
hydroxi
group
thu
valu
vicin
proton
proton
coupl
within
pch
ech
ch
ech
n
subunit
ca
hz
observ
free
rotat
around
bond
allow
adopt
hbond
stabilis
antiperiplanar
conform
along
pch
e
ch
bond
j
hz
j
hz
j
j
pe
rotat
around
chech
n
bond
unrestrict
j
hz
j
hz
establish
conform
behaviour
extens
nmr
studi
conduct
mhz
valu
j
hz
j
hz
well
j
j
j
pe
hz
evid
along
pchech
bond
phosphon
exist
antiperiplanar
conform
base
valu
j
j
hz
j
hz
j
hz
one
may
suggest
along
ch
ech
n
bond
rotat
almost
free
anticip
full
conform
freedom
along
tetramethylen
linker
butylphosphon
confirm
valu
j
heh
hz
methylen
group
fig
scheme
reagent
condit
cuso
equiv
sodium
ascorb
equiv
h
oeetoh
mw
c
min
scheme
reagent
condit
cuso
equiv
sodium
ascorb
equiv
h
oeetoh
mw
c
min
scheme
reagent
condit
propargyl
bromid
equiv
k
co
equiv
dmf
rt
h
scheme
reagent
condit
tmsbr
ch
cl
rt
h
c
ir
kbr
n
cm
h
nmr
mhz
cdcl
ch
j
hz
oh
ddd
j
hz
j
hz
j
hz
pcch
h
b
ddd
j
hz
j
hz
j
hz
pcch
h
b
dddd
j
hz
j
hz
j
hz
j
hz
pch
oh
methyl
azid
g
mmol
n
propargyltheobromin
g
mmol
phosphon
g
obtain
white
powder
purif
silica
gel
chloroformemethanol
vv
mp
c
ir
kbr
n
cm
h
nmr
mhz
cdcl
ab
j
hz
ch
h
b
ab
j
hz
ch
h
b
ddd
j
hz
j
hz
j
hz
pcch
h
b
ddd
j
hz
j
hz
j
hz
pcch
h
b
pch
oh
poch
ch
dd
j
hz
j
hz
ch
ch
j
hz
poch
ch
j
hz
poch
ch
c
nmr
mhz
methyl
azid
g
mmol
n
propargyltheophyllin
g
mmol
phosphon
g
obtain
white
powder
chromatographi
silica
gel
column
chloroformemethanol
vv
mp
c
ir
kbr
n
cm
h
nmr
mhz
cdcl
ab
j
hz
ch
h
b
ab
j
hz
ch
h
b
ddd
j
hz
j
hz
j
hz
pcch
h
b
dd
j
hz
j
hz
ddd
j
hz
j
hz
j
hz
pcch
h
b
pch
oh
v
ir
film
n
cm
h
nmr
mhz
cdcl
dd
j
hz
j
hz
ddd
j
hz
j
hz
j
hz
j
hz
dt
j
hz
j
hz
ab
j
hz
ch
h
b
ab
j
hz
ch
h
b
dd
j
hz
j
hz
pccch
h
b
pcchch
h
b
poch
ch
br
oh
pch
j
hz
poch
ch
j
hz
poch
ch
c
nmr
mhz
cdcl
c
hc
c
hc
c
j
hz
pcc
j
hz
poc
j
hz
poc
j
hz
pccc
j
hz
pc
j
hz
pocc
p
nmr
mhz
cdcl
ppm
anal
calcd
c
h
n
p
c
h
n
found
c
h
n
diethyl
yl
methyl
propylphosphon
azid
g
mmol
n
propargylthymin
g
mmol
phosphon
g
obtain
white
powder
chromatographi
silica
gel
column
chloroformemethanol
vv
mp
c
ir
kbr
n
cm
h
nmr
mhz
cdcl
br
nh
j
hz
hc
ch
ab
j
hz
ch
h
b
ab
j
hz
ch
h
b
pccch
poch
ch
ddd
j
hz
j
hz
j
hz
pch
oh
pcch
oh
j
hz
ch
j
hz
poch
ch
j
hz
poch
ch
c
nmr
mhz
cd
od
c
c
j
hz
pc
j
hz
poc
j
hz
poc
j
hz
pccc
j
hz
pcc
j
hz
pocc
j
hz
pocc
p
nmr
mhz
cdcl
ppm
ch
h
b
ab
j
hz
ch
h
b
pccch
poch
ch
ddd
j
hz
j
hz
j
hz
pch
oh
ch
ch
ddddd
j
hz
j
hz
j
hz
j
hz
j
hz
pcch
h
b
ddddd
j
hz
j
hz
j
hz
j
hz
j
hz
pcch
h
b
j
hz
poch
ch
j
hz
poch
ch
c
nmr
mhz
sever
acycl
nucleosid
nucleotid
exhibit
antivir
anticanc
activ
howev
case
clinic
use
antivir
nucleosid
hamper
drug
resist
andor
toxic
problem
circumst
intens
search
new
drug
effect
chemotherapi
virus
hiv
herp
viru
hepat
virus
cytomegaloviru
conduct
mani
laboratori
larg
number
modif
introduc
nucleobas
sugar
moieti
natur
nucleosid
consequ
sever
analogu
like
adefovir
tenofovir
cidofovir
fig
synthesis
furanos
ring
readili
hydrolys
phosphat
ester
linkag
present
natur
nucleotid
replac
acycl
chain
phosphon
moieti
respect
drug
discoveri
replac
canon
nucleobas
substitut
fivememb
heterocycl
ring
imidazol
triazol
particularli
success
ribavirin
aica
bredinin
tsao
analogu
best
known
exampl
among
analogu
fig
effort
field
led
synthesi
sever
analogu
contain
modifi
nucleobas
moieti
among
compound
nucleobas
mimet
substitut
triazol
link
methylen
group
special
interest
fig
moreov
sever
compound
possess
ring
show
cytostat
antivir
antibacteri
antifung
activ
convent
synthesi
reli
cycloaddit
alkyn
organ
azid
usual
provid
mixtur
regioisom
recent
discoveri
copper
effici
regiospecif
catalyst
transform
provid
gener
mild
approach
prepar
deriv
continu
studi
nucleotid
analogu
new
seri
modifi
phosphonyl
cyclonucleosid
bear
select
nucleobas
mimet
moieti
scheme
synthesis
subject
biolog
evalu
compound
ael
obtain
cycloaddit
azidoalkylphosphon
propargyl
nucleobas
n
propargyladenin
n
propargylthymin
n
propargyluracil
n
propargylcytosin
mimet
nucleobas
n
benzoyln
n
propargyltheophyllin
n
propargyltheobromin
n
propargyltheophyllin
propargylbenzimidazol
requir
azidoalkylphosphon
synthesis
accord
procedur
describ
previous
except
n
benzoyln
alkyn
use
paper
alreadi
describ
literatur
n
benzoyln
synthesis
overal
yield
three
step
begin
bisn
n
benzoyl
follow
select
n
debenzoyl
propargyl
scheme
n
previous
obtain
less
yield
structur
n
benzoyln
confirm
basi
h
c
nmr
ir
spectral
data
final
prove
cosi
noesi
experi
fig
obtain
good
yield
cycloaddit
carri
microwav
oven
c
approach
caus
signific
improv
puriti
final
product
allow
shorten
reaction
time
h
room
temperatur
min
irradi
sinc
synthes
phosphonyl
alreadi
describ
biolog
activ
evalu
n
propargyladenin
n
propargylthymin
n
propargyluracil
n
acetyln
propargylcytosin
react
two
azidophosphon
howev
mimet
nucleobas
appli
cycloaddit
seven
azidophosphon
scheme
sinc
preliminari
experi
demonstr
antivir
activ
compound
herp
simplex
virus
hel
cell
cultur
ec
mm
felin
herp
viru
ec
mm
crfk
cell
cultur
phosphon
synthesis
order
establish
influenc
fuse
phenyl
ring
observ
activ
scheme
synthesi
n
benzoyln
propargyluracil
propargyl
n
benzoyluracil
propargyl
bromid
scheme
appear
effici
comparison
previous
describ
approach
n
benzoyluracil
propargyl
alcohol
via
mitsunobu
reaction
yield
final
use
bromotrimethylsilan
select
diethyl
phosphon
transform
respect
phosphon
acid
good
yield
scheme
synthesis
compound
aem
evalu
antivir
activ
wide
varieti
dna
rna
virus
use
follow
cellbas
assay
human
embryon
lung
hel
ganciclovir
cidofovir
acyclovir
brivudin
adenin
dhpa
hippeastrum
hybrid
agglutinin
hha
urtica
dioica
agglutinin
uda
dextran
sulphat
molecular
weight
ribavirin
oseltamivir
carboxyl
amantadin
rimantadin
use
refer
compound
antivir
activ
express
ec
compound
concentr
requir
reduc
viru
plaqu
format
vzv
reduc
virusinduc
cytopathogen
virus
cytotox
test
compound
toward
uninfect
host
cell
defin
minimum
cytotox
concentr
mcc
caus
microscop
detect
alter
normal
cell
morpholog
cytotox
concentr
cc
caus
decreas
cell
viabil
determin
use
colorimetr
mt
assay
system
among
deriv
test
compound
three
carbon
fragment
phosphoru
atom
ring
substitut
n
benzoyln
show
moder
activ
herp
simplex
virus
ec
mm
hel
cell
cultur
felin
herp
viru
ec
mm
crfk
cell
cultur
cytostat
activ
test
compound
defin
cytostat
inhibitori
concentr
ic
caus
decreas
cell
prolifer
determin
murin
leukaemia
human
lymphocyt
cem
human
cervix
carcinoma
hela
cell
compound
cytostat
mm
sever
compound
show
moder
inhibitori
prolifer
tumour
cell
line
tabl
although
case
compound
seem
preferenti
cytostat
human
tumour
cell
line
esp
lymphocyt
cem
cell
murin
cell
particular
compound
antiprolif
ic
valu
rang
mm
structureeact
relationship
studi
seri
aem
g
j
reveal
cytostat
activ
compound
substitut
ring
n
regardless
length
linker
carbon
atom
deriv
activ
toward
cem
cell
line
eg
ic
ae
mm
also
hela
cell
furthermor
compound
select
inhibit
prolifer
human
tlymphocyt
cem
could
expect
phosphon
acid
found
inact
biolog
test
includ
acid
correspond
diethyl
ester
display
signific
activ
vs
vs
full
agreement
observ
lipophil
phosphon
ester
better
penetr
membran
comparison
phosphon
acid
thu
suffici
concentr
ester
achiev
cell
undergo
reaction
compound
contain
three
methylen
linker
phosphoru
atom
ring
substitut
n
benzoyln
activ
herp
simplex
virus
ec
mm
hel
cell
cultur
felin
herp
viru
ec
mm
crfk
cell
cultur
establish
presenc
quinazolin
ring
appear
necessari
display
antivir
activ
sinc
structur
analogu
lack
condens
phenyl
ring
compound
found
inact
ec
mm
new
seri
aem
effici
obtain
diethyl
azidomethyl
n
benzoyln
synthesis
sequenc
reaction
includ
bisn
n
benzoyl
follow
select
n
debenzoyl
propargyl
standard
condit
tmsbr
ethanol
sever
odiethyl
phosphon
g
j
transform
respect
phosphon
acid
synthesis
compound
evalu
varieti
dna
rna
virus
compound
contain
three
carbon
linker
phosphoru
atom
ring
substitut
n
benzoyln
show
moder
activ
ec
synthesis
compound
also
evalu
antiprolif
activ
three
tumour
cell
line
cem
hela
sever
compound
ie
found
activ
preferenti
inhibitori
toward
tlymphocyt
cem
cell
prolifer
ir
spectral
data
measur
infin
ftir
spectromet
melt
point
determin
boetiu
apparatu
uncorrect
element
analys
perform
microanalyt
laboratori
faculti
perkin
elmer
pe
chn
analyz
follow
adsorb
use
column
chromatographi
merck
silica
gel
mesh
analyt
tlc
merck
tlc
plastic
sheet
silica
gel
f
tlc
plate
develop
chloroformemethanol
solvent
system
visualis
spot
effect
iodin
vapour
solvent
purifi
method
describ
literatur
microwav
irradi
experi
carri
microwav
reactor
plazmartonika
rm
reaction
carri
ml
glass
vial
benzoyl
chlorid
ml
mol
ad
stir
suspens
g
mol
dri
acetonitril
ml
contain
dri
pyridin
ml
room
temperatur
h
product
concentr
reduc
pressur
residu
partit
dichloromethan
ml
water
ml
organ
layer
dri
mgso
concentr
vacuo
residu
crystallis
ethanol
give
g
white
powder
mp
c
ir
kbr
mixtur
g
mmol
dioxan
ml
n
k
co
aq
ml
stir
room
temperatur
h
glacial
acet
acid
ad
ph
product
concentr
reduc
pressur
residu
stir
satur
aqueou
sodium
bicarbon
ml
room
temperatur
h
solid
filter
wash
cold
water
dri
air
crude
product
chromatograph
silica
gel
column
chloroformemethanol
suspens
n
g
mmol
potassium
carbon
g
mmol
propargyl
bromid
ml
mmol
dmf
ml
stir
room
temperatur
h
mixtur
coevapor
toluen
ml
residu
dissolv
chloroform
theophyllin
inhibitori
concentr
compound
concentr
requir
inhibit
tumour
cell
prolifer
ml
wash
brine
ml
suspens
n
benzoyluracil
g
mmol
potassium
carbon
g
mmol
propargyl
bromid
ml
mmol
dmf
ml
stir
room
temperatur
h
mixtur
coevapor
toluen
ml
residu
dissolv
chloroform
ml
wash
brine
ml
organ
phase
dri
mgso
concentr
vacuo
crystallis
methanol
diethyl
ether
give
compound
g
white
solid
mp
c
solut
azidoalkylphosphon
mmol
etoh
ml
h
ml
ad
cuso
mmol
sodium
ascorb
mmol
alkyn
mmol
suspens
microwav
irradi
microwav
reactor
plazmatronika
rm
w
c
min
cool
solvent
remov
vacuum
evapor
residu
suspend
dri
chloroform
ml
filter
layer
celit
solut
concentr
vacuo
crude
product
purifi
silica
gel
column
chloroformemethanol
mixtur
vv
give
appropri
record
soon
reach
complet
control
virusinfect
cell
cultur
treat
test
compound
antivir
concentr
express
ec
effect
compound
concentr
requir
inhibit
virusinduc
cytopath
cytotox
test
compound
monitor
microscop
visibl
alter
cell
morpholog
express
minim
cytotox
concentr
mcc
compound
concentr
requir
afford
microscop
detect
alter
cell
cultur
morpholog
cytostat
activ
test
compound
determin
cytostat
concentr
ic
compound
concentr
requir
inhibit
cell
prolifer
purpos
cell
seed
mlwell
microtit
plate
allow
prolifer
murin
leukaemia
human
tlymphocyt
cem
human
cervix
carcinoma
hela
day
absenc
presenc
differ
serial
concentr
test
compound
end
exponenti
prolifer
phase
cell
count
autom
coulter
zi
particl
counter
anali
ghent
belgium
